Reglan Odt is a drug owned by Meda Pharmaceuticals Inc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 09, 2018. Details of Reglan Odt's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6221392 | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) |
Expired
|
| US6024981 | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Reglan Odt is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Reglan Odt's family patents as well as insights into ongoing legal events on those patents.
Reglan Odt's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Reglan Odt's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 09, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Reglan Odt Generic API suppliers:
Metoclopramide Hydrochloride is the generic name for the brand Reglan Odt. 38 different companies have already filed for the generic of Reglan Odt, with Hospira having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Reglan Odt's generic
Alternative Brands for Reglan Odt
There are several other brand drugs using the same active ingredient (Metoclopramide Hydrochloride) as Reglan Odt. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Evoke Pharma Inc |
| |
| Salix Pharms |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Metoclopramide Hydrochloride, Reglan Odt's active ingredient. Check the complete list of approved generic manufacturers for Reglan Odt
About Reglan Odt
Reglan Odt is a drug owned by Meda Pharmaceuticals Inc. Reglan Odt uses Metoclopramide Hydrochloride as an active ingredient. Reglan Odt was launched by Meda Pharms in 2005.
Approval Date:
Reglan Odt was approved by FDA for market use on 10 June, 2005.
Active Ingredient:
Reglan Odt uses Metoclopramide Hydrochloride as the active ingredient. Check out other Drugs and Companies using Metoclopramide Hydrochloride ingredient
Dosage:
Reglan Odt is available in tablet, orally disintegrating form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING | Discontinued | ORAL |
| EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING | Discontinued | ORAL |